Intermittent preventive treatment of infants with mefloquine reduces risk of clinical malaria in areas of moderate malaria transmission and high resistance to sulphadoxine-pyrimethamine, but safety and tolerability issues need consideration.

Ítems similars

• Plasma and whole blood mefloquine concentrations during treatment of chloroquine-resistant falciparum malaria with the combination mefloquine-sulphadoxine-pyrimethamine.
  per: Karbwang, J, et al.
  Publicat: (1987)
• Determinants of the uptake of intermittent preventive treatment of malaria in pregnancy with sulphadoxine pyrimethamine in Sabatia Sub County, Western Kenya
  per: Mutanyi, JA, et al.
  Publicat: (2021)
• Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial.
  per: Shulman, C, et al.
  Publicat: (1999)
• Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
  per: Peto, T, et al.
  Publicat: (1985)
• Tolerability of amodiaquine and sulphadoxine-pyrimethamine, alone or in combination for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan adults.
  per: Fanello, C, et al.
  Publicat: (2006)